Speaker, Dr Martin Williams, Psychedelic Research in Science & Medicine [PRISM]
Bio: Martin Williams, PhD has a research background is in Medicinal Chemistry and Pharmacology. Martin has been a co-investigator on a number of Australian clinical trials of psychedelic-assisted psychotherapy, including the St Vincent’s Hospital Melbourne study of psilocybin-assisted psychotherapy in palliative care; the Monash PsiConnect neuroimaging study of psilocybin with mindfulness meditation; the Swinburne pilot study and 3PAP RCT of 2- vs 3-dose psilocybin-assisted therapy for depression; and several other studies of psilocybin, MDMA and other psychedelics for the treatment of a range of mental health conditions. Martin has been an articulate advocate for psychedelic medical research and the evidence-based clinical translation of psychedelic-assisted therapies for almost twenty years. He has co-authored several papers providing an Australian perspective, presents regularly at conferences and symposia, and is a commentator on psychedelic research and governance in Australian print and broadcast media.
